Astellas Pharma, Inc. (ALPMY)
16.84
+0.34
(+2.03%)
USD |
OTCM |
Nov 13, 16:00
Astellas Pharma Shareholders Equity (Quarterly) : 12.61B for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 12.61B |
| June 30, 2026 | 11.95B |
| March 31, 2026 | 11.50B |
| December 31, 2025 | 11.25B |
| September 30, 2025 | 10.92B |
| June 30, 2025 | 10.26B |
| March 31, 2025 | 10.12B |
| December 31, 2024 | 9.505B |
| September 30, 2024 | 10.70B |
| June 30, 2024 | 10.42B |
| March 31, 2024 | 10.55B |
| December 31, 2023 | 10.66B |
| September 30, 2023 | 10.99B |
| June 30, 2023 | 10.92B |
| March 31, 2023 | 11.33B |
| December 31, 2022 | 11.90B |
| September 30, 2022 | 11.40B |
| June 30, 2022 | 11.33B |
| March 31, 2022 | 12.03B |
| December 31, 2021 | 12.73B |
| September 30, 2021 | 12.71B |
| June 30, 2021 | 12.46B |
| March 31, 2021 | 12.54B |
| December 31, 2020 | 13.26B |
| September 30, 2020 | 12.60B |
| Date | Value |
|---|---|
| June 30, 2020 | 12.11B |
| March 31, 2020 | 11.94B |
| December 31, 2019 | 12.12B |
| September 30, 2019 | 11.99B |
| June 30, 2019 | 11.60B |
| March 31, 2019 | 11.37B |
| December 31, 2018 | 11.78B |
| September 30, 2018 | 11.29B |
| June 30, 2018 | 11.52B |
| March 31, 2018 | 11.93B |
| December 31, 2017 | 12.13B |
| September 30, 2017 | 12.00B |
| June 30, 2017 | 11.74B |
| March 31, 2017 | 11.41B |
| December 31, 2016 | 11.26B |
| September 30, 2016 | 12.12B |
| June 30, 2016 | 11.60B |
| March 31, 2016 | 11.20B |
| December 31, 2015 | 10.99B |
| September 30, 2015 | 11.05B |
| June 30, 2015 | 10.90B |
| March 31, 2015 | 10.99B |
| December 31, 2014 | 11.46B |
| September 30, 2014 | 11.81B |
| June 30, 2014 | 12.14B |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 47.20B |
| Daiichi Sankyo Co., Ltd. | 11.19B |
| Eisai Co., Ltd. | 5.708B |
| Chugai Pharmaceutical Co., Ltd. | 13.29B |
| Santen Pharmaceutical Co., Ltd. | 1.936B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 22.45B |
| Total Liabilities (Quarterly) | 9.828B |
| Debt to Equity Ratio | 0.2144 |
| Current Ratio | 1.313 |
| Net Debt Paydown Yield | 2.66% |